Beacon Biosignals
Beacon Biosignals is a neurotechnology company focused on bringing precision neuroscience into clinical trials and treatments for brain- and sleep-related disorders. The company’s core offering includes an FDA-cleared wearable device (the Waveband headband) that captures high-fidelity EEG during sleep and wake states, combined with an AI-driven analytics platform that processes millions of hours of neural data to extract biomarkers of brain function. Its end-to-end solution supports pharmaceutical and biotech clients by providing tools for patient stratification, dose-response monitoring, and early-stage disease progression, enabling trials to be more precise and efficient.
HQ: Boston, Massachusetts, United States
Country: USA

Establishment Year:
2019

Company Stage:
Mature

Estimated Employees:
101 .. 250

Estimated Revenues
$M 12.00

Raised Funding:
$M 116.00

AI Categories: